https://www.PR.com/ Latest news releases from PR.com for DelveInsight. Mon, 13 Apr 2026 01:38:18 -0400 © 2026 PR.com 60 en-us https://www.PR.com/images/logo_white.jpg https://www.PR.com/ 68 69 PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles. https://www.pr.com/press-release/760471 Mon, 30 Jul 2018 12:30:05 -0400 According to the latest report of DelveInsight, “Graft Versus Host Disease (GVHD) - Market Insights, Epidemiology, and Market Forecast-2027,” in 2016, there were 9,847 and 9,006 cases of aGvHD and cGvHD, respectively, in 7 MM. [PR.com] https://www.pr.com/press-release/760471 DelveInsight https://www.pr.com/press-release/701417 Fri, 13 Jan 2017 03:00:00 -0500 DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. [PR.com] https://www.pr.com/press-release/701417 DelveInsight https://www.pr.com/press-release/701117 Wed, 11 Jan 2017 03:00:00 -0500 DelveInsight's report provides the market outlook of Acne Vulgaris. The major aim of the Report is to understand the market size of indication and market potential and future share of emerging drugs to understand the possible market opportunities in this sector. [PR.com] https://www.pr.com/press-release/701117 DelveInsight https://www.pr.com/press-release/696436 Fri, 25 Nov 2016 03:00:00 -0500 DelveInsight, a leading market research and consulting company, is offering discounts on its market research reports. [PR.com] https://www.pr.com/press-release/696436 DelveInsight https://www.pr.com/press-release/694992 Sun, 13 Nov 2016 03:00:00 -0500 DelveInsight, the leading market research and consulting company, has added a new report, Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. [PR.com] https://www.pr.com/press-release/694992 DelveInsight https://www.pr.com/press-release/693344 Sun, 30 Oct 2016 03:00:00 -0400 DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. [PR.com] https://www.pr.com/press-release/693344 DelveInsight https://www.pr.com/press-release/692790 Thu, 27 Oct 2016 03:00:00 -0400 DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. [PR.com] https://www.pr.com/press-release/692790 DelveInsight https://www.pr.com/press-release/691302 Sat, 15 Oct 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company, has added a new report, Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. [PR.com] https://www.pr.com/press-release/691302 DelveInsight https://www.pr.com/press-release/691133 Fri, 14 Oct 2016 03:00:00 -0400 DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. [PR.com] https://www.pr.com/press-release/691133 DelveInsight https://www.pr.com/press-release/690620 Sun, 09 Oct 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company, has added a new report, Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. [PR.com] https://www.pr.com/press-release/690620 DelveInsight https://www.pr.com/press-release/690631 Sun, 09 Oct 2016 03:00:00 -0400 DelveInsight is delighted to announce the launch of its report store. The report store is collection of 3000+ analytical reports from the pharmaceutical as well as biotechnological industry. The store lets you browse through the vast collection of reports, gives you an overview of the different types of reports on offering, and provides an idea of the report through the "Table of Contents" and [PR.com] https://www.pr.com/press-release/690631 DelveInsight https://www.pr.com/press-release/687687 Sat, 17 Sep 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company, has added new report Aspergillosis - Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/687687 DelveInsight https://www.pr.com/press-release/685583 Thu, 01 Sep 2016 03:00:00 -0400 DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. [PR.com] https://www.pr.com/press-release/685583 DelveInsight https://www.pr.com/press-release/685215 Sun, 28 Aug 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company, has added a new report Endometrial Cancer- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio. [PR.com] https://www.pr.com/press-release/685215 DelveInsight https://www.pr.com/press-release/684318 Sun, 21 Aug 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company, has added a new report Ewing’s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 to its portfolio. [PR.com] https://www.pr.com/press-release/684318 DelveInsight https://www.pr.com/press-release/683834 Thu, 18 Aug 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report T-Cell Lymphoma - Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/683834 DelveInsight https://www.pr.com/press-release/682595 Sun, 07 Aug 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added the new report Gram Negative Bacterial Infections - Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/682595 DelveInsight https://www.pr.com/press-release/681676 Sun, 31 Jul 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/681676 DelveInsight https://www.pr.com/press-release/680677 Sun, 24 Jul 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Phosphoinositide 3-Kinase (PI3k) Inhibitors – Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/680677 DelveInsight https://www.pr.com/press-release/679662 Sat, 16 Jul 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/679662 DelveInsight https://www.pr.com/press-release/677561 Fri, 01 Jul 2016 03:00:00 -0400 The report provides information on the therapeutic development based on the Natural Killer Cells across 35+ pipeline drugs and 20+ companies active in this field. DelevInsight's Report also provides the comparative analysis of Natural Killer Cells at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also highlights [PR.com] https://www.pr.com/press-release/677561 DelveInsight https://www.pr.com/press-release/676443 Thu, 23 Jun 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Diabetic Nephropathy - Pipeline Insights, 2016 to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. [PR.com] https://www.pr.com/press-release/676443 DelveInsight https://www.pr.com/press-release/675969 Sun, 19 Jun 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Ovarian Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. [PR.com] https://www.pr.com/press-release/675969 DelveInsight https://www.pr.com/press-release/675551 Fri, 17 Jun 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added a new report Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016 to its portfolio. [PR.com] https://www.pr.com/press-release/675551 DelveInsight https://www.pr.com/press-release/673425 Thu, 02 Jun 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added a new report, "Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016" to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. [PR.com] https://www.pr.com/press-release/673425 DelveInsight https://www.pr.com/press-release/672607 Thu, 26 May 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. [PR.com] https://www.pr.com/press-release/672607 DelveInsight https://www.pr.com/press-release/671111 Tue, 17 May 2016 11:42:39 -0400 DelveInsight, the leading market research and consulting company has added a new report Acute Ischemic Stroke - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. [PR.com] https://www.pr.com/press-release/671111 DelveInsight https://www.pr.com/press-release/670923 Sat, 14 May 2016 03:00:00 -0400 DelveInsight has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its Portfolio. [PR.com] https://www.pr.com/press-release/670923 DelveInsight https://www.pr.com/press-release/670928 Sat, 14 May 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. [PR.com] https://www.pr.com/press-release/670928 DelveInsight https://www.pr.com/press-release/670592 Thu, 12 May 2016 03:00:00 -0400 According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. [PR.com] https://www.pr.com/press-release/670592 DelveInsight https://www.pr.com/press-release/670330 Wed, 11 May 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. [PR.com] https://www.pr.com/press-release/670330 DelveInsight https://www.pr.com/press-release/667071 Sat, 16 Apr 2016 03:00:00 -0400 DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. [PR.com] https://www.pr.com/press-release/667071 DelveInsight https://www.pr.com/press-release/666564 Wed, 13 Apr 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight's expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market [PR.com] https://www.pr.com/press-release/666564 DelveInsight https://www.pr.com/press-release/664534 Wed, 30 Mar 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/664534 DelveInsight https://www.pr.com/press-release/663002 Sat, 19 Mar 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/663002 DelveInsight https://www.pr.com/press-release/662819 Fri, 18 Mar 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/662819 DelveInsight https://www.pr.com/press-release/662612 Thu, 17 Mar 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/662612 DelveInsight https://www.pr.com/press-release/662456 Wed, 16 Mar 2016 03:00:00 -0400 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/662456 DelveInsight https://www.pr.com/press-release/661342 Tue, 08 Mar 2016 03:00:00 -0500 DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. [PR.com] https://www.pr.com/press-release/661342 DelveInsight https://www.pr.com/press-release/660557 Thu, 03 Mar 2016 03:00:00 -0500 DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. [PR.com] https://www.pr.com/press-release/660557 DelveInsight